These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1107360)

  • 61. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 62. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 63. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
    Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
    [No Abstract]   [Full Text] [Related]  

  • 64. [Randomized double-blind study of loxapine as compared with diazepam in therapy of patients with anxiety neuroses].
    De Rosa E; De Rosa G; Coppi R; Zannella F; Pepe C
    Clin Ter; 1980 Oct; 95(2):127-46. PubMed ID: 7009029
    [No Abstract]   [Full Text] [Related]  

  • 65. A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients.
    Pecknold JC; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):14-5. PubMed ID: 329322
    [No Abstract]   [Full Text] [Related]  

  • 66. [Multidimensional diagnostics in pharmacopsychiatry/results of therapy with desmethyl-loxapine (author's transl)].
    Bergener M; Escher HD; Linden KJ
    Arzneimittelforschung; 1976 Feb; 26(2):290-9. PubMed ID: 820358
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Loxapine update: 1966-1976.
    Ayd FJ
    Dis Nerv Syst; 1977 Nov; 38(11):883-7. PubMed ID: 410614
    [No Abstract]   [Full Text] [Related]  

  • 69. Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
    Contreras SA; Maas JW; Seleshi E; Bowden CL
    Biol Psychiatry; 1988 Nov; 24(7):818-22. PubMed ID: 3067756
    [No Abstract]   [Full Text] [Related]  

  • 70. A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
    Schiele BC; Janecek J; Zimmermann R
    Compr Psychiatry; 1969 Sep; 10(5):355-60. PubMed ID: 4389944
    [No Abstract]   [Full Text] [Related]  

  • 71. "Refractory" patients and loxapine: schizophrenia or mania?
    Steele TE
    Am J Psychiatry; 1982 May; 139(5):701-2. PubMed ID: 7072863
    [No Abstract]   [Full Text] [Related]  

  • 72. Loxapine in neurotic anxiety: some modifiers of treatment response.
    Rickels K; Weise CC; Feldman H; Fee EA; Wiswesser G
    J Int Med Res; 1978; 6(3):180-5. PubMed ID: 348533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Seizures induced by acute loxapine overdose.
    Peterson CD
    Am J Psychiatry; 1981 Aug; 138(8):1089-91. PubMed ID: 7258388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
    Ewing DG; Einarson TR
    Am J Psychiatry; 1981 Dec; 138(12):1631-2. PubMed ID: 7304801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
    Gottfries CG
    Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
    [No Abstract]   [Full Text] [Related]  

  • 76. A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
    Bankier RG
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):44-7. PubMed ID: 4566123
    [No Abstract]   [Full Text] [Related]  

  • 77. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
    Doongaji DR; Satoskar RS; Sheth AS; Apte JS; Desai AB; Shah BR
    J Postgrad Med; 1989 Jan; 35(1):3-8. PubMed ID: 2685263
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
    Gallant DM; Bishop G; Steel CA; Bishop MP
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.